From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications
The mainstay of moderate to severe Crohn's disease (CD), anti-TNF treatment, shows no clinical benefit in ∼40% of patients, likely due to incomplete cellular targeting and delayed treatment institution. While single-target therapeutics have been highly effective for some CD patients, substantia...
Guardado en:
Autores principales: | Shikha Nayar, Judy H. Cho |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2edd0d56275e427b91380fd2fdfcbd3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Microambiente medular en la leucemia mieloide crónica: su relación con la enfermedad y la respuesta al tratamiento
por: Aristizábal,José Alejandro, et al.
Publicado: (2014) -
Paradoxical SAPHO syndrome observed during anti-TNF-α therapy for Crohn's disease
por: Amano H, et al.
Publicado: (2017) -
Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis
por: Xue-Pei Zhang, et al.
Publicado: (2021) -
Current Overview on the Use of Mesenchymal Stem Cells for Perianal Fistula Treatment in Patients with Crohn’s Disease
por: Marcin Włodarczyk, et al.
Publicado: (2021) -
Caspase-3/NLRP3 signaling in the mesenchymal stromal niche regulates myeloid-biased hematopoiesis
por: Jing Zhang, et al.
Publicado: (2021)